Infanrix Hexa Vaccine

Infanrix Hexa Vaccine is an antiretroviral medication classified under combination vaccines, featuring the active components Diphtheria tetanus, Haemophil, Hepatitis B, Pertussis, and Poliomyelitis. This vaccine safeguards your child against Diphtheria tetanus, Haemophil, Hepatitis B, Pertussis, and Poliomyelitis. Diphtheria is a severe bacterial infection that primarily impacts the airways and occasionally the skin. The swelling of the airways can lead to significant breathing difficulties and, in some cases, suffocation. Tetanus, commonly referred to as lockjaw, is a bacterial infection caused by Clostridium tetani, which can result in muscle stiffness and spasms. Haemophil (Hib) is a bacterium responsible for serious infections, such as pneumonia, meningitis, and throat infections, particularly in young children. Hepatitis B is a viral infection that affects the liver, potentially leading to chronic liver disease and an increased risk of liver cancer. Pertussis, or whooping cough, is a highly contagious respiratory infection caused by Bordetella pertussis. Poliomyelitis, known as polio, is a viral infection that can result in paralysis and muscle weakness.

Infanrix Hexa should not be given if your child has an allergy to this vaccine or any of its components. Allergic reactions may present as itchy skin, rashes, shortness of breath, or swelling of the face or tongue. If your child has had nervous system issues within seven days after a previous whooping cough vaccination, the Infanrix Hexa Vaccine should not be administered. Most importantly, this vaccine should not be given if your child has a severe infection with a temperature exceeding 38°C. While minor infections, like a cold, may not be a concern, it is recommended to consult a doctor beforehand. If your child has a fever, it is wise to seek advice from a healthcare professional before proceeding with the vaccine. They can evaluate whether the vaccination should be postponed until the fever subsides or if it is safe to continue.